Corvus Pharmaceuticals - 48 Year Dividend History | CRVS

Historical dividend payout and yield for Corvus Pharmaceuticals (CRVS) since 1971. The current TTM dividend payout for Corvus Pharmaceuticals (CRVS) as of June 25, 2019 is $0.00. The current dividend yield for Corvus Pharmaceuticals as of June 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.100B $0.000B
Corvus Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of immuno-oncology therapies to harness the immune system to attack cancer cells. Its products include CPI-444, Adenosine production inhibitor, Adenosine A2B antagonist and Interleukin-2 (IL-2)-inducible T cell kinase (ITK) inhibitors. Corvus Pharmaceuticals, Inc. is based in Burlingame, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.734B 12.75
Gilead Sciences (GILD) United States $87.764B 10.66
Bio-Techne Corp (TECH) United States $7.796B 53.19